Keiji Tasaka

13PUBLICATIONS
56CO-AUTHORS
Haematological tumoursPredictive and prognostic markersAdolescent healthCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 30, 2025
Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell-type chronic active EBV infection.

Ryo Akazawa, Takashi Mikami, Masaki Yamada

|Jul 31, 2024
MGMT protein expression is a reliable predictive biomarker for temozolomide-containing chemotherapy in osteosarcoma.

Yoshinori Uchihara, Katsutsugu Umeda, Yosuke Yamada

|Dec 21, 2023
RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia.

Hirohito Kubota, Hiroo Ueno, Keiji Tasaka

|Apr 17, 2023
High-dose carboplatin-irinotecan-temozolomide is an effective salvage chemotherapy for relapsed or refractory neuroblastoma.

Hirokazu Kobushi, Satoshi Saida, Katsutsugu Umeda

|Dec 31, 2021
Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma.

Keiji Tasaka, Hiroo Ueno, Kai Yamasaki

|Oct 30, 2021
Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia.

Takashi Mikami, Itaru Kato, James Badger Wing

Pageof 3

Frequent Collaborators

9 joint publications

Katsutsugu Umeda

8 joint publications

Itaru Kato

5 joint publications

Satoshi Saida

4 joint publications

Junko Takita